Catalyst Wire Dossier Catalyst Wire Dossier

BASAGLAR KWIKPEN

Insulin glargine · Eli Lilly and Company
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for BASAGLAR KWIKPEN, covering 2015-12-16 to 2021-07-20. Get the full timeline:

Most recent: FDA Approved: BASAGLAR KWIKPEN — Supplemental Application (Eli Lilly and Company)

See pricing